Press Releases
-
Bio-Gate expands customer base for antiviral and antibacterial products
May 30, 2021
-
Qvirus Platform Released Oncolytic Vesicular Stomatitis Virus Service For Virus-related Project
May 24, 2021
-
CUREBASE UNLOCKS DRUG DEVELOPMENT WITH REMOTE CLINICAL TRIALS; RAISES $15M LED BY GGV CAPITAL
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities.
May 24, 2021
-
IntegrateRNA Offers High-quality Oligonucleotide Conjuagted Services to Facilitate Diagnostic And Targeted Drug Delivery
May 24, 2021
-
Alfa Chemistry Materials Presents Carbon Nanotubes and Graphene with High Quality on its Website
The past decade has witnessed an increasing demand for novel materials such as carbon nanotubes and graphenes. To facilitate researcher’s purchase of novel material chemicals, Alfa Chemistry Materials, a material subsidiary of Alfa Chemistry, recently announces that both carbon nanotubes and graphenes with high quality are now presented as main featured products on its website.
May 24, 2021
-
Creative Biostructure Established Various Systems for Protein Expression in Pharmaceutical Field
May 25, 2021
-
Creative BioMart Biomarker Provides a Variety of Platforms for Imaging Biomarker Detection
May 25, 2021
-
Matexcel Provides Professional Product Analysis Services to Meet Evolving Demands
May 25, 2021
-
Lifeasible Provides a Full Range of Methods for Phytochemical Tests
May 25, 2021
-
WCG IRB Welcomes 2021 Class to International Fellows Program on Research Ethics
This annual program builds upon WCG IRB’s expertise and 50-year legacy of global service, protecting the safety of clinical trial participants, and preserving the scientific integrity of research protocols. The 2021 program offers virtual training globally, continuing efforts to improve IRB operations worldwide and educate the next generation of research leaders amid the COVID-19 pandemic.
May 31, 2021
-
Mission of Protheragen MedAI: to Seek Innovative Solutions for Drug Discovery and Life Science Research
Jun 1, 2021
-
Protheragen MedAI Releases Protein Structure Modeling Service
Jun 1, 2021
-
CD Formulation Is Able to Conduct API-Excipient Compatibility Analysis
Jun 1, 2021
-
eClinical Solutions to Showcase Data Strategies for Digital and Decentralized Trials at PHUSE, DIA and Other Key Industry Events
Mansfield, MA, May 27, 2021 — eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services that accelerate digital clinical initiatives, today announced that their thought leaders will be participating in a variety of industry events this spring to discuss the impact of data on future clinical trials. As data sources increase due to the demands for decentralized and patient-centric trials, sponsors and CROs are experiencing longer timelines for clinical data review, management and analyses.
Jun 1, 2021
-
eClinical Solutions Shares Business Strategies for Accelerated Clinical Trials Post Covid-19
eClinical thought leaders to discuss decentralized trials, digital transformation of clinical research and modernized clinical data infrastructures at upcoming industry events
Apr 12, 2021
-
Crucial Data Solutions and SISCAPA Assay Technologies Partner to Introduce a New Approach to Diagnostics and Remote Health Monitoring
Together, CDS and SAT are leveraging the latest mobile and wearable technologies to achieve remote, longitudinal tracking of biomarkers in clinical trials
Apr 12, 2021
-
BOC Sciences Provides Extensive Catalog of Isotope Labeled Products
Apr 13, 2021
-
TRIO Partners with eClinical Solutions to Power Digital Transformation in Clinical Trials for Cancer
Global clinical research organization selects eClinical’s elluminate clinical data platform to optimize trial efficiency and speed
Apr 14, 2021
-
ComputaBio Has Launched Molecular Dynamics Simulation Services for Drug R&D Projects
ComputaBio, a US supplier of professional computational biology services, has launched molecular dynamics simulation services for industrial and academic customers to expedite the process of drug design.
Apr 5, 2021
-
New Healthcare Industry Survey Reveals Majority of Healthcare Organizations Unprepared for ONC Cures Act Final Rule
Apr 5, 2021






